These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9233738

  • 1. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
    Newman PJ, Quinn AC, Grounds RM, Hunter JM, Boyd AH, Eastwood NB, Pollard BJ, Pearson AJ, Harper NJ, Beale RJ, Sutjarittam M, Elliot JM, Bion JF.
    Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738
    [Abstract] [Full Text] [Related]

  • 2. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients.
    Pearson AJ, Harper NJ, Pollard BJ.
    Intensive Care Med; 1996 Jul; 22(7):694-8. PubMed ID: 8844237
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ, Vender J, Howard D, Casale EJ, Murray MJ.
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [Abstract] [Full Text] [Related]

  • 4. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M, Mok Q.
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [Abstract] [Full Text] [Related]

  • 5. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
    Mellinghoff H, Radbruch L, Diefenbach C, Buzello W.
    Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
    [Abstract] [Full Text] [Related]

  • 6. Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.
    Brandom BW, Woelfel SK, Ference A, Dayal B, Cook DR, Kerls S.
    J Clin Anesth; 1998 May; 10(3):195-9. PubMed ID: 9603588
    [Abstract] [Full Text] [Related]

  • 7. Comparative study on the pharmacodynamics of cisatracurium: continuous infusion or intermittent bolus injection.
    Dong YJ, Li X.
    Contemp Clin Trials; 2012 May; 33(3):482-5. PubMed ID: 22269820
    [Abstract] [Full Text] [Related]

  • 8. [Effect of sevoflurane versus propofol-remifentanil anesthesia on neuromuscular blockade by continuous cisatracurium infusion].
    Wen LL, Lin WQ, Zhao WX, Li GC, Bai XH, Xiao JB.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):163-5. PubMed ID: 20118012
    [Abstract] [Full Text] [Related]

  • 9. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients.
    Lagneau F, D'honneur G, Plaud B, Mantz J, Gillart T, Duvaldestin P, Marty J, Clyti N, Pourriat JL.
    Intensive Care Med; 2002 Dec; 28(12):1735-41. PubMed ID: 12447516
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The clinical pharmacology of cisatracurium].
    Mellinghoff H, Diefenbach C.
    Anaesthesist; 1997 Jun; 46(6):481-5. PubMed ID: 9297378
    [Abstract] [Full Text] [Related]

  • 12. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB, Walker SC, Fontenot JP.
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [Abstract] [Full Text] [Related]

  • 13. Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics.
    Jellish WS, Brody M, Sawicki K, Slogoff S.
    Anesth Analg; 2000 Nov; 91(5):1250-5. PubMed ID: 11049917
    [Abstract] [Full Text] [Related]

  • 14. Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.
    Meeder AM, van der Steen MS, Rozendaal A, van Zanten AR.
    BMJ Case Rep; 2016 Oct 03; 2016():. PubMed ID: 27698008
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ, Beaufort TM, Fuchs-Buder T.
    Drugs; 2001 Oct 03; 61(7):919-42. PubMed ID: 11434449
    [Abstract] [Full Text] [Related]

  • 18. Tachyphylaxis associated with continuous cisatracurium versus pancuronium therapy.
    Kanji S, Barletta JF, Janisse JJ, Kruse JA, Devlin JW.
    Pharmacotherapy; 2002 Jul 03; 22(7):823-30. PubMed ID: 12126215
    [Abstract] [Full Text] [Related]

  • 19. Cisatracurium dosing in a patient with hyperthermia.
    Lim J, Cox J, Nguyen T, Arya R.
    Am J Health Syst Pharm; 2019 Jul 02; 76(14):1029-1032. PubMed ID: 31361873
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH, Eastwood NB, Parker CJ, Hunter JM.
    Br J Anaesth; 1996 Mar 02; 76(3):382-8. PubMed ID: 8785138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.